CD4+NKG2D+ T cells of CLL patients comprised a heterogeneous population of cells, as 51% of them were CD4+CD8+, 18% were CD4+CD56+ and 30% lacked CD8 and CD56 expression. This evidence concerns the gene NCAM1 and B-cell chronic lymphocytic leukemia.